1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for Efficacy of Inotuzumab Ozogamicin When Used As Salvage/Bridging Therapy Prior to CD19-Directed CAR T-Cell Therapy in Relapsed/Refractory B-ALL: A Single-Center Experience$

ALL - 772

Efficacy of Inotuzumab Ozogamicin When Used As Salvage/Bridging Therapy Prior to CD19-Directed CAR T-Cell Therapy in Relapsed/Refractory B-ALL: A Single-Center Experience

Anupa John

Poster Presenter: Anupa John

MPN - 855

Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

Zarema Abdulkhalikova

Poster Presenter: Zarema Abdulkhalikova

SOHO 2026 Annual Meeting

Posters by Title

Efficacy of Inotuzumab Ozogamicin When Used As Salvage/Bridging Therapy Prior to CD19-Directed CAR T-Cell Therapy in Relapsed/Refractory B-ALL: A Single-Center Experience

Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

Efficacy of Olverembatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) With Prior Resistance to Ponatinib or Asciminib and ASXL1 Mutations

Efficacy of Revumenib in Acute Myeloid Leukemia Harboring NPM1-Mutated Co-Mutations: Post Hoc Analysis of AUGMENT-101

Efficacy of Talicabtagene Autoleucel in Relapsed/Refractory B-NHL in Complete Response at the Time of Infusion: A Single-Center Study

Efficacy of Vemurafenib in Relapsed/Refractory Hairy Cell Leukemia: A Systematic Review and Meta Analysis

Efficacy of Venetoclax-Based Therapy in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Efficacy Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) and Baseline Renal Impairment Treated With at Least 2 Prior Lines of Therapy in the DREAMM-7 Trial

Efficacy, Safety, and Resistance in Pirtobrutinib-Treated CLL/SLL After Covalent BTK Inhibitor Failure: A Systematic Review of the BRUIN Trial Program